Seoul Viosys and SETi’s Violeds Technology Proves 99.9% Sterilization of Coronavirus (COVID-19) in 30 Seconds
Seoul Viosys (KOSDAQ: 092190) and Sensor Electronic Technology, Inc. (“SETi”), leading global innovators of UV LED products and technology, announced that it has been successful in achieving 99.9% sterilization of coronavirus (COVID-19) in 30 seconds. Tests were conducted with the research group of Korea University, Korea’s top rank university, by using a compound semiconductor Violeds technology that is being mass-produced.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200402005348/en/
Fig 1. COVID-19 after sterilized by Violeds (Graphic: Business Wire)
As COVID-19 spread throughout the world, SETi and Seoul Viosys, the fourth-largest global LED maker of Seoul Semiconductor’s affiliates, devoted resources to show how Violeds technology can directly sterilize the virus. The goal has always been to provide technology for a cleaner world, and this includes minimizing the spread of COVID-19, while the company will quickly offer strong sterilization solutions for coronavirus in air as well as surface of goods such as facial masks and smartphones.
In the study by SETi and Seoul Viosys, Violeds technology is used to show just how strong the sterilization effect can be on COVID-19 when exposed to Violeds photons for 30 seconds. The study also finds the coronavirus becomes even more sterile when placed closer to the photon with longer exposure time. In addition to testing the coronavirus, the Violeds technology also proved to be successful in sterilizing 99.9% of other harmful bacteria such as Escherichia coli, Staphylococcus Aureus, Pseudomonas Aeruginosa, Klebsiella Pneumoniae, and Salmonella Typhimurium.
Violeds, compound semiconductor technology, is the brand name of technology that utilizes UV LED for sterilization and deodorization functions. This concept clean technology has been developed by Seoul Viosys with SETi since 2005 to prevent germ proliferation through the use of a light source (photon) without the need of chemicals that could be harmful to humans. Violeds technology, which has been recognized for its excellent sterilization and stability, has also been used to clean environments for astronauts at NASA’s space station in the United States. Until now, general commercial applications have been limited, as their lifetime was too short for prolonged use. However, since 2019, new patented technology has extended the previous life span by 50,000 hours, making it now the optimal solution for air purification and water sterilization products.
Seoul Semiconductor, Seoul Viosys of South Korea, and SETi Inc. of the United States, focuses solely on compound semiconductors. The company holds more than 14,000 patents, in addition to spending over $100 million a year on research and development. CEO Chung Hoon Lee, who is son of farmer himself, said when Jimmy Carter, the son of a farmer, became the president of the United States, it has become a turning point in life. He expressed “new history in the light” and “I hope this success story will be a small but heart-breaking story for small and medium-sized manufacturing companies and young start-ups who are dreaming of manufacturing”.
About Seoul Viosys
Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured No. 1 market share in the UV LED industry (LEDinside, 2018). Seoul Viosys has an extensive UV LED portfolio with all wavelengths range (200nm to 1600nm) including ultraviolet rays (UV), visible rays and infrared rays. It holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for strong sterilization and disinfection (UVC), skin regeneration (UVB), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add the advanced VCSEL technology which supports smartphone facial recognition and autonomous driving, and has started its mass production. In January 2020, it introduced disruptive “Micro Clean Pixel” that has potential to be game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/.
About SETi
Sensor Electronic Technology, inc. (SETi), a division of Seoul Semiconductor and Seoul Viosys, is a company based in Columbia, South Carolina, founded in 1999 by four Ph.D., for research and development of compound semiconductors in the United States. In 2005, SETi received the investment and R&D fund from Seoul Semiconductor and Seoul Viosys. For the development project, SETi is also working with the University of South Carolina and the University of California at Santa Barbara, adding depth to its research and development.
Currently, SETi is the only company in the world that can produce UV LEDs from 200nm to 430nm. To learn more, visit http://www.s-et.com/en/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200402005348/en/
Contact information
Media Contacts:
Seoul Semiconductor Co., Ltd.
Jeonghee Kim
Tel: +82-70-4391-8311
Email: jeonghee.kim@seoulsemicon.com
North America
Andrew Smith
Tel: (901) 831-6614
Email: andrew.smith@seoulsemicon.com
Sales Contacts:
Americas
Mike Berens
mberens@s-et.com
Asia
Dong Ju Kim
djkim@seoulviosys.com
Europe
Marko Hofmann
marko.hofmann@seoulviosys.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
I-care Becomes a Unicorn23.12.2025 10:45:00 CET | Press Release
I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil
Liquid Reply Joins the Agentic AI Foundation (AAIF) to Advance Open, Trusted Agentic AI23.12.2025 10:00:00 CET | Press Release
Liquid Reply, specialising in platform engineering and cloud-native technologies within the Reply Group, today announced that it has joined the Agentic AI Foundation (AAIF). The newly established foundation was launched under the auspices of the Linux Foundation and provides a neutral, open governance framework for the development of agent-based AI systems. Members collaborate transparently to develop tools, protocols, and specifications that remain available as open-source resources for the global community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223604862/en/ Through its membership, Liquid Reply will engage the AAIF community and actively support the establishment of open standards for the next generation of AI-powered applications. By joining the AAIF, Liquid Reply reinforces its commitment to open-source and community-driven innovation, and supports the creation of shared technical foundations for the responsi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
